Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Pfizer’s ADCETRIS combination regimen secures FDA approval for relapsed large B-cell lymphoma
The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc.’s supplemental Biologics License Application (sBLA) for ADCETRIS (brentuximab vedotin) in combination with lenalidomide and ... Read More
FDA approves Genentech’s Evrysdi tablet as first SMA treatment in tablet form
In a significant development for the treatment of spinal muscular atrophy (SMA), the U.S. Food and Drug Administration (FDA) has approved Genentech’s Evrysdi tablet, marking ... Read More
AnaptysBio shares soar 37% after rheumatoid arthritis candidate rosnilimab delivers promising Phase 2b trial results
AnaptysBio, Inc. experienced a significant boost in its market performance as shares surged 37% in premarket trading following the announcement of promising results from its ... Read More
Neuphoria Therapeutics secures milestone payment from Merck as Alzheimer’s clinical trial advances
Neuphoria Therapeutics Inc. (Nasdaq: NEUP), a late-stage biotechnology company focused on developing treatments for neuropsychiatric disorders, has announced that it will receive a $15 million ... Read More
Xilio Therapeutics accelerates cancer immunotherapy with new masked T cell engager programs and $52m AbbVie collaboration
Xilio Therapeutics, Inc., a clinical-stage biotechnology company based in Waltham, Massachusetts, has announced the development of three new masked T cell engager programs designed to ... Read More
Selkirk Pharma launches ClinFAST to accelerate clinical trial manufacturing
Selkirk Pharma, Inc., a privately held pharmaceutical manufacturer based in Spokane, Washington, has introduced ClinFAST, a new service designed to eliminate one of the most ... Read More
Lupin shocks the market with massive profit gains in Q3 FY2025—here’s what you need to know
Lupin Limited, a leading global pharmaceutical company, has reported strong financial results for the third quarter of fiscal year 2025, reflecting its strategic focus on ... Read More
Breakthrough in oral lichen planus? Lipella Pharmaceuticals’ LP-310 delivers promising results
Lipella Pharmaceuticals has announced encouraging topline results from its Phase 2a dose-ranging trial for LP-310, a liposomal-tacrolimus oral rinse formulation designed to treat oral lichen ... Read More
Bain Capital’s $3.3bn acquisition of Mitsubishi Tanabe Pharma aims to reshape Japan’s pharmaceutical landscape
Bain Capital, a prominent global private investment firm, has announced a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi ... Read More
Axsome Therapeutics wins big in Auvelity patent battle, stock jumps 14%
Axsome Therapeutics Inc. experienced a sharp rise in its share price, climbing 14% in premarket trading following the announcement of a settlement agreement with Teva ... Read More